Avastin extended median survival by approximately four months in patients with metastatic colorectal cancer, at a cost of around $100,000.

“i believe the answer with avastin was on the order of four months with avastin which cost at the time in the neighborhood of a hundred thousand dollars it was going to extend median survival for those patients by four months”